Vaughan David Investments INC Increased Johnson & Johnson (JNJ) Stake by $15.62 Million; Shares Declined

May 16, 2018 - By Billy Entrekin

Johnson & Johnson (NYSE:JNJ) Corporate LogoDuring Q4 2017 the big money sentiment increased to 0.87. That’s change of 0.04, from 2017Q3’s 0.83. 35 investors sold all, 884 reduced holdings as JNJ ratio increased. 654 rose stakes while 143 funds bought stakes. Funds hold 1.72 billion shares thus 0.40% more from 2017Q3’s 1.71 billion shares. M&R Cap Mgmt invested in 2.09% or 64,508 shs. White Pine Inv Co invested in 1.21% or 17,531 shs. Robeco Institutional Asset Mgmt Bv invested 0.94% in Johnson & Johnson (NYSE:JNJ). Arrowgrass (Us) Ltd Partnership invested in 0.05% or 36,997 shs. Natixis holds 1.16% or 1.08 million shs. Hugh Johnson Advsrs Limited Liability owns 0.27% invested in Johnson & Johnson (NYSE:JNJ) for 6,540 shs. Harvest Capital Mgmt reported 28,567 shs. Schulhoff holds 56,210 shs. Cornerstone Capital invested in 156,194 shs. Pioneer Trust Natl Bank N A Or accumulated 37,053 shs. Polar Capital Llp reported 1.23M shs. Eagle Ridge Invest Management stated it has 27,522 shs. Benedict Finance Incorporated stated it has 3.54% in Johnson & Johnson (NYSE:JNJ). Weiss Multi reported 216,744 shs. Manchester Capital Limited Liability accumulated 22,345 shs or 0.46% of the stock.

JNJ registered $20.17 million net activity with 0 insider purchases and 1 insider sale since February 15, 2018.

According to 2017Q4 Securities and Exchange filling the Vaughan David Investments Inc increased its holdings in Johnson & Johnson (JNJ) by 63.99%. The company’s stock sank 9.21% while Vaughan David Investments Inc bought 112,372 shares. The institutional investor is holding 287,975 shares, compared to the 175,603 from the previous quarter. And the announced value of the major pharmaceuticals company is $40.24M for the 2017Q4. Johnson & Johnson has $336.53 billion market cap. The stock increased 0.27% or $0.34 during the last trading session, hitting $125.47.Johnson & Johnson has volume of 2.25 million shares. Since May 16, 2017 JNJ has risen 1.12% and is uptrending. JNJ underperformed by 10.43% the S&P 500.

Vaughan David Investments Inc reduced its stake in Marathon Petroleum Corp (NYSE:MPC) by 602,879 shares to 4,700 shares, valued at $310,000 in 2017Q4, according to the filing. It manages about $1.81 billion and $2.16 billion US Long portfolio. Vaughan David Investments Inc has cut its stake in General Dynamics Corp (NYSE:GD) and also reduced its holding in Mcdonalds Corporation (NYSE:MCD) by 30,245 shares in the quarter, for a total of 6,795 shares.

For more Johnson & Johnson (NYSE:JNJ) news posted briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or 247Wallst.com. The titles are as follows: “Johnson & Johnson Sells Off After Earnings” posted on April 22, 2018, “Johnson & Johnson: Waiting On The Wave” on May 11, 2018, “More states sue over opioid epidemic” with a publish date: May 16, 2018, “What Can I Expect To Make If I Invest In Johnson & Johnson Today?” and the last “Johnson & Johnson Commits to Yet Another Dividend Hike” with publication date: April 26, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Total analysts of 10 have positions in Johnson & Johnson (NYSE:JNJ) as follows: 5 rated it a “Buy”, 1 with “Sell” and 4 with “Hold”. The positive are 50%. Since January 2, 2018 according to StockzIntelligence Inc Johnson & Johnson has 17 analyst reports. On Friday, January 12 the firm earned “Buy” rating by Wells Fargo. On Tuesday, January 23 the stock has “Sell” rating by BTIG Research. On Wednesday, January 24 the company was maintained by Stifel Nicolaus. On Tuesday, February 6 the rating was maintained by Wells Fargo with “Buy”. On Wednesday, April 18 the firm has “Buy” rating given by Wells Fargo. On Wednesday, April 18 the stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given by Deutsche Bank. On Tuesday, April 10 the firm has “Equal-Weight” rating by Morgan Stanley given. On Tuesday, January 16 the firm earned “Buy” rating by Jefferies. On Wednesday, April 18 the stock has “Hold” rating by Stifel Nicolaus. In Tuesday, February 27 report Citigroup maintained it with “Neutral” rating and $146 target.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: